Skip to main content

End of Q4 update from REPROCELL (2022-23)

Did you know that REPROCELL is celebrating its 20th anniversary this year? If you missed the commemorative letter from our CEO we have included a link below - plus everything else we’ve been up to since the start of 2023.

  1. Celebrating the 20th Anniversary of REPROCELL: A letter from our CEO Chika Yokoyama [LETTER]
  2. From rat aorta to resistance arteries: measuring vascular contractility [BLOG]
  3. Make a Difference with Fresh Residual Human Tissue Donation for Research – How to Get Involved! [BLOG]
  4. Everything you need to know about the motilin receptor [BLOG]
  5. Everything you need to know about the FDA Modernization Act 2.0 [BLOG]
  6. Clinical Trials: An Evolutionary Perspective [BLOG]
  7. Recombinant Human Laminins and their Use in Cell Culture [BLOG]

If you have any questions about our products and services, please reach out via our website - until then we wish you all the best for the new financial year.

Subscribe to receive updates from REPROCELL